FB2026_01 , released March 12, 2026
FB2026_01 , released March 12, 2026
Allele: Dmel\RNaseZF155L.ΔPAM.Tag:V5
Open Close
General Information
Symbol
Dmel\RNaseZF155L.ΔPAM.Tag:V5
Species
D. melanogaster
Name
FlyBase ID
FBal0391503
Feature type
allele
Associated gene
Dmel\RNaseZ
Associated Insertion(s)
Carried in Construct
P{RNaseZ.F155L.ΔPAM.V5}
Key Links
Genomic Maps

Transgenic product class
missense_variant
(Migunova et al., 2023)
silent_mutation
(Migunova et al., 2023)
synonymous_variant
(Migunova et al., 2023)
Mutagen
Nature of the Allele
Transgenic product class
missense_variant
(Migunova et al., 2023)
silent_mutation
(Migunova et al., 2023)
synonymous_variant
(Migunova et al., 2023)
Mutagen
in vitro construct
(Migunova et al., 2023)
Progenitor genotype
Carried in construct
P{RNaseZ.F155L.ΔPAM.V5}
Cytology
Description

6.6kb genomic fragment containing the complete RNaseZ coding region plus 3kb upstream and 1kb downstream sequence. A single nucleotide mutation has been introduced into each of the three PAM sites targeted by RNaseZU6.3xsgRNA, so that this transgene is resistant to CRISPR/Cas9 targeting using RNaseZU6.3xsgRNA (the first nucleotide change (G to T) is in non-coding sequence, the remaining two changes (G to A and G to C) are silent mutations within the open reading frame). A F155L amino acid substitution has been introduced into the coding sequence. This change is equivalent to a variant that is linked with cardiomyopathy in the orthologous human gene. The coding sequence is tagged with Tag:V5.

(Migunova et al., 2023)
Allele components
Component
Use(s)
Regulatory region(s)
RNaseZ
Encoded product / tool
RNaseZ
Tagged with
Tag:V5
Mutations Mapped to the Genome
Curation Data
Type
Location
Additional Notes
References
point_mutation
2R:10,309,201..10,309,201 [-]
Nucleotide change:

T10309201C

Reported nucleotide change:

T?C

Amino acid change:

F155L | RNaseZ-PB

Reported amino acid change:

F155L

Comment:

Analogous mutation in human ELAC2 implicated in cardiomyopathy with combined oxidative phosphorylation deficiency 17; mutation carried on in vitro construct.

(Migunova et al., 2023)
Variant Molecular Consequences
Associated Sequence Data
DDBJ / EMBL / GenBank
DNA sequence
Protein sequence
 
UniProtKB/Swiss-Prot
    UniProtKB/TrEMBL
      Expression Data
      Reporter Expression
      Additional Information
      Statement
      Reference
       
      Marker for
      Reflects expression of
      Reporter construct used in assay
      Human Disease Associations
      Disease Ontology (DO) Annotations
      Models Based on Experimental Evidence ( 1 )
      Modifiers Based on Experimental Evidence ( 0 )
      Disease
      Interaction
      References
      Comments on Models/Modifiers Based on Experimental Evidence ( 0 )
       
      Disease-implicated variant(s)
       
      This allele represents a human variant implicated in disease.
      (Migunova et al., 2023)
      ELAC2:p.Phe154Leu
      (FlyBase curators, 2019-)
      Variants Synonym(s)
      Associated human disease model(s)
      External database links
      ClinVar: 66037
      Comments concerning this variant
      Phenotypic Data
      Interactions
      Show genetic interaction network for Enhancers & Suppressors
      Phenotypic Class
      Phenotype Manifest In
      Additional Comments
      Genetic Interactions
      Statement
      Reference
      Xenogenetic Interactions
      Statement
      Reference
      Complementation and Rescue Data
      Comments
      Images (0)
      Mutant
      Wild-type
      Stocks (0)
      Notes on Origin
      Discoverer
      External Crossreferences and Linkouts ( 0 )
      Synonyms and Secondary IDs (1)
      Reported As
      Symbol Synonym
      RNaseZF155L.ΔPAM.Tag:V5
      Name Synonyms
      Secondary FlyBase IDs
        References (2)